We are live on
!
Find out more
CAM
Cacti Asset Management Portfolio holdings
AUM
$1.99B
1-Year Est. Return
86.33%
This Fund
S&P 500
This Quarter
Est. Return
+7.9%
1 Year Est. Return
+86.33%
3 Year Est. Return
+168.13%
5 Year Est. Return
+181.76%
10 Year Est. Return
+521.65%
AUM
$1.35B
AUM Growth
+$114M
(+9.3%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
1.33%
Top 10 Holdings %
Top 10 Hldgs %
48.53%
Holding
92
New
4
Increased
25
Reduced
4
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$11.9M |
| 2 |
Goldman Sachs
GS
|
+$425K |
| 3 |
Lindblad Expeditions
LIND
|
+$354K |
| 4 |
UNIFI
UFI
|
+$297K |
| 5 |
Blackstone
BX
|
+$193K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baker Hughes
BKR
|
+$7.73M |
| 2 |
Microsoft
MSFT
|
+$217K |
| 3 |
LM
Legg Mason, Inc.
LM
|
+$189K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$89K |
| 5 |
Value Line
VALU
|
+$71K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.46% |
| 2 | Industrials | 18.61% |
| 3 | Technology | 18.09% |
| 4 | Healthcare | 18.03% |
| 5 | Communication Services | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Eli Lilly
LLY
$1.01T
| $107K | 0.01% |
1,000
| – | – |
|
77
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$315M
| $71K | 0.01% |
1,875
| – | – |
|
78
PJT Partners
PJT
$3.9B
| $66K | ﹤0.01% |
1,250
| – | – |
|
|
VSLR
79
DELISTED
VIVINT SOLAR, INC.
VSLR
| $52K | ﹤0.01% |
10,000
| – | – |
|
80
Berkshire Hathaway Class B
BRK.B
$1.11T
| $43K | ﹤0.01% |
200
| – | – |
|
81
Home Depot
HD
$302B
| $21K | ﹤0.01% |
100
| – | – |
|
|
82
Value Line
VALU
$362M
| – | – |
-3,000
| Closed | -$71K |
|
|
LM
83
DELISTED
Legg Mason, Inc.
LM
| – | – |
-5,400
| Closed | -$189K |
|
Similar funds
BGGS
KOCAA
CC
SC
NL
TMC
SB
CC
Cacti Asset Management's Q3 2018 Portfolio in Review
As of Q3 2018, Cacti Asset Management held 92 positions worth $1.35B, up 9.3% from $1.24B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Cacti Asset Management's Q3 2018 filing shows 4 new, 25 increased, 4 reduced and 3 closed positions. Its largest new stake was Teva Pharmaceutical Industries Limited: 513,724 shares worth $10.9M. The largest sale was Baker Hughes, an estimated $7.73M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
- Cacti Asset Management's largest Q3 2018 buy was Teva Pharmaceutical Industries Limited: 513,724 shares worth $10.9M.
- Cacti Asset Management added most to Goldman Sachs in Q3 2018, an estimated $425K increase.
- Cacti Asset Management's biggest Q3 2018 reduction was Baker Hughes, cutting an estimated $7.73M.
- Cacti Asset Management fully exited Legg Mason, Inc. in Q3 2018, selling an estimated $189K.
- Cacti Asset Management's ten largest holdings make up 49% of its $1.35B portfolio in Q3 2018.
- Cacti Asset Management opened 4 new positions and closed 3 in Q3 2018.
- Cacti Asset Management's portfolio value rose 9.3% quarter-over-quarter to $1.35B.
Based on Cacti Asset Management's 13F filing for Q3 2018, filed 1 Oct 2018.